All but two PMS schemes post gains in July, but most underperform Nifty

Only 25 per cent of the 180 schemes under consideration managed to beat the 7.5 per cent gains posted by Nifty 50

All except two portfolio management services (PMS) schemes ended with gains in July. However, only 25 per cent of the 180 schemes under consideration managed to beat the 7.5 per cent gains posted by the Nifty50. 

The large-cap PMS category gained 5.5 per cent in July, underperforming the Nifty, while the mid-cap category returned 6.3 per cent, higher than Nifty MidCap 100’s 5.2 per cent. 

The small-cap and multi-cap PMS categories surged 7.2 per cent and 6 per cent, respectively, underperforming Nifty SmallCap 100 (8.5 per cent) and Nifty500 (6.6 per cent).  

For a one-year period, 115 out of 164 schemes outperformed the Nifty50. Wize Market Analytics Capital Mind - Momentum Portfolio is the top performer with returns of 63.5 per cent, followed by Kotak’s Pharma strategy (52.4 per cent) and Valcreate Investment Managers Life Sciences & Specialty Opportunities (43.3 per cent).